PA Consulting Group

Recent papers from PA Consulting Group

1. Decision-making, optimisation, and risk-based asset management: a case study in DominicaInfrastructure Asset Management · 2026
2. A narrative review of progress and lessons from a decade of implementing infection prevention and control in Sierra Leone following the Ebola epidemicDiscover Public Health · 2026
3. Qualitative testing of EQ-HWB-9 self-complete and proxy versions in older adult-carer dyads in HungaryHealth and Quality of Life Outcomes · 2026
4. Alfvénic Poynting Flux Characterized by a Substorm‐SMC Cycle and Ionospheric InfluenceSpace Weather · 2026
5. A novel small molecule remyelination therapy for multiple sclerosisnpj Drug Discovery. · 2026
6. Concentrations of Per- and Polyfluoroalkyl Substances in the Rainwater of South-Eastern AustraliaEnvironmental Toxicology and Chemistry · 2026
7. Mandibular Advancement Device Therapy in 182 DISE-Selected Adults with Moderate-to-Severe Obstructive Sleep Apnea: A Multicenter Real-World StudyBiomedicines · 2026
8. A framework for assessing climate costs and economic benefits of major entertainment eventsCommunications Sustainability · 2026
9. Noticing and responding to end-of-life suffering in the PICU: A co-designed conceptual framework for nursing practiceIntensive and Critical Care Nursing · 2026
10. Defining Digital Peer Support: A Framework to Preserve Core Values in the Rush to DigitizePsychiatric Services · 2026
11. Exploring capacity building needs for effective public-private partnerships in Ethiopia’s water service sectorEnvironmental Management Economics and Policy · 2026
12. Valuation of soil productivity in farmland pricesAgricultural Finance Review · 2026
13. Damage Quantification in Exclusionary Abuse CasesThe Antitrust Bulletin · 2026
14. Pharmacokinetics of Ertugliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor (SGLT2i) in Horses After Enteral AdministrationVeterinary Sciences · 2026
15. Caregiver- and Clinician-Reported Symptoms in Pediatric Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Receiving LeniolisibSHILAP Revista de lepidopterología · 2026
16. Symptom Changes in Pediatric Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Receiving LeniolisibSHILAP Revista de lepidopterología · 2026
17. E067 Paediatric rheumatology and timely access to non-inflammatory care: findings and recommendations from the Getting it Right First Time (GIRFT) ReportLara D. Veeken · 2026
18. P075 Paediatric rheumatology and timely access to care for children and young people with inflammatory conditions: findings and recommendations from the Getting it Right First Time (GIRFT) reportLara D. Veeken · 2026
19. Abstract CT050: Preliminary clinical results of TAVO412, an anti-EGFR/cMET/VEGF multispecific antibody, in patients with advanced or metastatic solid tumorsCancer Research · 2026
20. ‘ It's like calling short people vertically challenged’: Language and terminology preferences among neurodivergent adults in the United KingdomNeurodiversity · 2026